Evaxion A/S
EVAX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001828253
No open-market purchases or sales by Evaxion A/S insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.93M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Evaxion A/S changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 12 | 9 | −3 |
| Shares | 678.5K | 227.0K | −451.6K (−66.6%) |
| Value | $2.06M | $442.0K | −$1.62M (−78.6%) |
New holders (2)
Institutions that held Evaxion A/S at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 11,600 | $22.0K | 0.00% |
| Group One Trading, L.P. | 100 | $0 | 0.00% |
Sold out (5)
Institutions that held Evaxion A/S at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Luminus Management LLC | 424,527 | $1.29M |
| Kepos Capital LP | 30,000 | $91.0K |
| Two Sigma Investments, LP | 20,590 | $62.0K |
| ETF Managers Group, LLC | 7,020 | $22.0K |
| Simplex Trading, LLC | 55 | $0 |